SUPERNUS PHARMACEUTICALS, INC. (SUPN)
$44.58+$0.39 (+0.88%) Today
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 5 | 35,999 | |
| Option exercise | 10 | 71,998 | |
| Tax withholding / forfeiture | 5 | 15,564 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
85 Form 4 filings on record, the earliest from Nov 8, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Frank Mottola - Officer | Grant or award | Common Stock | 1,125 | $0.00 | - | |
| Frank Mottola - Officer | Grant or award | Common Stock | 750 | $0.00 | - | |
| Frank Mottola - Officer | Grant or award | Common Stock | 1,250 | $0.00 | - | |
| Frank Mottola - Officer | Tax withholding / forfeiture | Common Stock | 603 | $51.35 | $31K | |
| Frank Mottola - Officer | Tax withholding / forfeiture | Common Stock | 368 | $50.86 | $19K | |
| Frank Mottola - Officer | Tax withholding / forfeiture | Common Stock | 670 | $50.86 | $34K | |
| Frank Mottola - Officer | Derivative | Restricted Stock Unit | 1,125 | $0.00 | - | |
| Frank Mottola - Officer | Derivative | Restricted Stock Unit | 750 | $0.00 | - | |
| Frank Mottola - Officer | Derivative | Restricted Stock Unit | 1,250 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Common Stock | 1,125 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Common Stock | 750 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Common Stock | 1,250 | $0.00 | - | |
| Jonathan Rubin - Officer | Tax withholding / forfeiture | Common Stock | 603 | $51.35 | $31K | |
| Jonathan Rubin - Officer | Tax withholding / forfeiture | Common Stock | 369 | $50.86 | $19K | |
| Jonathan Rubin - Officer | Tax withholding / forfeiture | Common Stock | 671 | $0.00 | - | |
| Jonathan Rubin - Officer | Derivative | Restricted Stock Unit | 1,125 | $0.00 | - | |
| Jonathan Rubin - Officer | Derivative | Restricted Stock Unit | 750 | $0.00 | - | |
| Jonathan Rubin - Officer | Derivative | Restricted Stock Unit | 1,250 | $0.00 | - | |
| Georges Gemayel - Director | Option exercise | Common Stock | 15,000 | $12.98 | $195K | |
| Georges Gemayel - Director | Grant or award | Common Stock | 4,475 | $0.00 | - | |
| Georges Gemayel - Director | Option exercise | Director Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Georges Gemayel - Director | Derivative | Restricted Stock Unit | 4,475 | $0.00 | - | |
 Bethany Sensenig - Director | Option exercise | Common Stock | 4,475 | $0.00 | - | |
| Bethany Sensenig - Director | Open-market sale | Common Stock | 3,258 | $51.27 | $167K | |
| Bethany Sensenig - Director | Open-market sale | Common Stock | 1,217 | $50.31 | $61K | |
| Bethany Sensenig - Director | Option exercise | Restricted Stock Unit | 4,475 | $0.00 | - | |
| Timothy C. Dec - Officer | Grant or award | Employee Stock Option (Right to Buy) | 17,500 | $0.00 | - | |
| Timothy C. Dec - Officer | Grant or award | Restricted Stock Unit | 3,000 | $0.00 | - | |
| Padmanabh P. Bhatt - Officer | Grant or award | Employee Stock Option (Right to Buy) | 13,500 | $0.00 | - | |
| Padmanabh P. Bhatt - Officer | Grant or award | Restricted Stock Unit | 3,000 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Employee Stock Option (Right to Buy) | 13,500 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Restricted Stock Unit | 3,000 | $0.00 | - | |
| Frank Mottola - Officer | Grant or award | Employee Stock Option (Right to Buy) | 13,500 | $0.00 | - | |
| Frank Mottola - Officer | Grant or award | Restricted Stock Unit | 3,000 | $0.00 | - | |
| Jack A. Khattar - Officer | Grant or award | Employee Stock Option (Right to Buy) | 341,610 | $0.00 | - | |
| Georges Gemayel - Director | Grant or award | Restricted Stock Unit | 2,989 | $0.00 | - | |
| Georges Gemayel - Director | Grant or award | Director Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
 Carrolee Barlow - Director | Grant or award | Restricted Stock Unit | 2,989 | $0.00 | - | |
| Carrolee Barlow - Director | Grant or award | Director Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
| Bethany Sensenig - Director | Grant or award | Restricted Stock Unit | 2,989 | $0.00 | - | |
| Bethany Sensenig - Director | Grant or award | Director Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
| Charles W. Newhall III - Director | Grant or award | Restricted Stock Unit | 2,989 | $0.00 | - | |
| Charles W. Newhall III - Director | Grant or award | Director Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
 Frederick M. Hudson - Director | Grant or award | Restricted Stock Unit | 2,989 | $0.00 | - | |
| Frederick M. Hudson - Director | Grant or award | Director Stock Option (Right to Buy) | 4,977 | $0.00 | - | |
| Charles W. Newhall III - Director | Option exercise | Common Stock | 15,000 | $12.98 | $195K | |
| Charles W. Newhall III - Director | Option exercise | Director Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Padmanabh P. Bhatt - Officer | Grant or award | Performance Share Unit | 1,500 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 81,250 | $25.30 | $2.06M | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 58,371 | $50.55 | $2.95M | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 1,529 | $51.46 | $79K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 81,250 | $0.00 | - | |
| Charles W. Newhall III - Director | Open-market sale | Common Stock | 23,800 | $50.73 | $1.21M | |
| Charles W. Newhall III - Director | Open-market sale | Common Stock | 1,200 | $51.55 | $62K | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 2,267 | $25.30 | $57K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 1,904 | $48.06 | $92K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 2,267 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 53,785 | $25.30 | $1.36M | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 40,173 | $48.07 | $1.93M | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 53,785 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 11,510 | $25.30 | $291K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 8,588 | $48.25 | $414K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 11,510 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 13,688 | $25.30 | $346K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 10,235 | $48.02 | $491K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 13,688 | $0.00 | - | |
| Jonathan Rubin - Officer | Option exercise | Common Stock | 1,875 | $0.00 | - | |
| Jonathan Rubin - Officer | Tax withholding / forfeiture | Common Stock | 840 | $46.21 | $39K | |
| Jonathan Rubin - Officer | Option exercise | Performance Share Unit | 1,875 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 47,940 | $12.98 | $622K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 29,513 | $47.23 | $1.39M | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 47,940 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 27,060 | $12.98 | $351K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 16,587 | $47.02 | $780K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 27,060 | $0.00 | - | |
| Frank Mottola - Officer | Option exercise | Common Stock | 5,000 | $39.40 | $197K | |
| Frank Mottola - Officer | Open-market sale | Common Stock | 5,000 | $45.87 | $229K | |
| Frank Mottola - Officer | Option exercise | Employee Stock Option (Right to Buy) | 5,000 | $0.00 | - | |
| Jonathan Rubin - Officer | Grant or award | Performance Share Unit | 1,875 | $0.00 | - | |
| Jack A. Khattar - Officer | Grant or award | Performance Share Unit | 20,000 | $0.00 | - | |
| Jack A. Khattar - Officer | Grant or award | Performance Share Units | 19,320 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 8,074 | $25.30 | $204K | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 6,322 | $46.29 | $293K | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 8,074 | $0.00 | - | |
| Jack A. Khattar - Officer | Option exercise | Common Stock | 73,176 | $25.30 | $1.85M | |
| Jack A. Khattar - Officer | Open-market sale | Common Stock | 55,578 | $46.01 | $2.56M | |
| Jack A. Khattar - Officer | Option exercise | Employee Stock Option (Right to Buy) | 73,176 | $0.00 | - |
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had 10 insider filings in the last 90 days, with the most recent on 2026-08-14. The full record for SUPN runs to 85 Form 4 filings, the earliest from 2024-11-08. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of SUPN were filed in the last 90 days.
No insider sales of SUPN were filed in the last 90 days. 53 sales are on record for this company.
This page tracks SUPN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add SUPN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
